GHRS

Conviction 80HealthcareScan · Mon, Aug 10, 2026

GHRS$29.51-2.51%

ResistanceSupportVol 14

Vol MA14 279.98K

May 11May 28Jun 16Jul 6Jul 23Aug 10

GH Research PLCBiotechnologywww.ghres.com ↗

Price29.51

Change-2.51%

Gap+0.26%

Rel volume0.76×

Avg volume331.9K

Avg $ vol9.56M

SMA 2028.40

SMA 5025.78

SMA 20018.41

Price vs 50+14.45%

Price vs 200+60.26%

MA stackbullish

50/200 cross—

Supertrendup · 25.83

RSI (14)60

MACD hist0.04

MACD crossbull · 2d

Stoch %K / %D62 / 78

ADX (14)33

+DI / −DI28 / 11

RSI divergence—

MACD divergenceBearish

ATR %+5.14%

ADR %5.32%

52w high30.64

52w low11.80

From 52w high-3.69%

Above 52w low+150.08%

New 52w highNo

SqueezeOn · 12d

Bollinger width14.04%

%B0.78

Donchian pos67.08%

Donchian high31.44

Donchian low25.58

AVWAP (52w high)30.14

vs AVWAP high-2.08%

AVWAP (52w low)17.52

vs AVWAP low+68.40%

OBV trendUp

Chaikin MF (20)0.03

Today vs 20d0.76×

Avg vol (14d)279.98K

Avg vol (20d)331.9K

Avg $ vol (20d)9.56M

Market cap1.83B

RS 3m (vs SPY)+38.38%

RS 6m (vs SPY)+107.48%

RS line new highNo

Trend template8/8

Technical rank91.5

1 week+4.68%

1 month+11.32%

3 months+37.77%

6 months+94.59%

1 year+143.88%

YTD+122.89%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target43.50

Target upside47.41%

Analyst ratingBuy

Institutional69.45%

Ent. value1.83B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out68.61M

Employees73

ListedFri, Jun 25, 2021

Free float45.24M

Float %72.9%

Short interest1.95M

Days to cover10.5d

Short volume32.1%

Squeeze score34 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.23 vs −$0.31

Last surprise+25.8% beat

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank91.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance30.03

Support20.39

Days since event—

Candle confirm—

News sentiment—

Congress activity

Disclosed STOCK Act trades in GHRS

All disclosures →

No recent disclosed trades by Congress in GHRS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in GHRS

No recent insider (Form 4) filings in GHRS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in GHRS · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.